Expression of EGFR, VEGF, and NOTCH1 Suggest Differences in Tumor Angiogenesis in HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma

[1]  R. Gibbs,et al.  Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1 , 2011, Science.

[2]  A. McKenna,et al.  The Mutational Landscape of Head and Neck Squamous Cell Carcinoma , 2011, Science.

[3]  B. Döme,et al.  Clinical significance of genetic alterations and expression of epidermal growth factor receptor (EGFR) in head and neck squamous cell carcinomas. , 2011, Oral oncology.

[4]  R. Fisher,et al.  Relationship between Epidermal Growth Factor Receptor Status, p16INK4A, and Outcome in Head and Neck Squamous Cell Carcinoma , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[5]  S. Kösling.  Trends in head and neck radiology , 2011, European Radiology.

[6]  Guo-Pei Yu,et al.  Population‐based analysis of oral and oropharyngeal carcinoma: Changing trends of histopathologic differentiation, survival and patient demographics , 2010, The Laryngoscope.

[7]  Anthony N. Snow,et al.  Human Papillomavirus Detection in Head and Neck Squamous Cell Carcinomas , 2010, Advances in anatomic pathology.

[8]  J. Grandis,et al.  Emerging drugs to treat squamous cell carcinomas of the head and neck , 2010, Expert opinion on emerging drugs.

[9]  Gypsyamber D'Souza,et al.  HPV-associated head and neck cancer: a virus-related cancer epidemic. , 2010, The Lancet. Oncology.

[10]  Jonathan R. Clark,et al.  Relationships between epidermal growth factor receptor expression and human papillomavirus status as markers of prognosis in oropharyngeal cancer. , 2010, European journal of cancer.

[11]  B. H. Abdullah,et al.  Immunohistochemical expression of epidermal growth factor receptor (EGFR) in oral squamous cell carcinoma in relation to proliferation, apoptosis, angiogenesis and lymphangiogenesis , 2010, Head & neck oncology.

[12]  Mu-Kuan Chen,et al.  Association of High Levels of Jagged-1 and Notch-1 Expression with Poor Prognosis in Head and Neck Cancer , 2010, Annals of Surgical Oncology.

[13]  F. Fang,et al.  Prognostic impact of p16, p53, epidermal growth factor receptor, and human papillomavirus in oropharyngeal cancer in a betel nut-chewing area. , 2010, Archives of otolaryngology--head & neck surgery.

[14]  W. Westra,et al.  Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus‐associated head and neck cancer based on a prospective clinical experience , 2010, Cancer.

[15]  Hui Gao,et al.  Upregulation of Notch pathway molecules in oral squamous cell carcinoma. , 2010, International journal of oncology.

[16]  Lun Zhang,et al.  Expression of Stat3 and Notch1 is associated with cisplatin resistance in head and neck squamous cell carcinoma. , 2010, Oncology reports.

[17]  Shi-fang Zhao,et al.  [Study on the effects of overexpression of exogenous Notch1 in tongue squamous cell carcinoma cells on cell growth and expression of epidermal growth factor receptor in vitro]. , 2010, Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology.

[18]  J. Grandis,et al.  The Molecular Pathogenesis of Head and Neck Cancer , 2010, Cancer biology & therapy.

[19]  Christine H Chung,et al.  Human Papillomavirus in Head and Neck Cancer: Its Role in Pathogenesis and Clinical Implications , 2009, Clinical Cancer Research.

[20]  D. Rimm,et al.  Defining Molecular Phenotypes of Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[21]  Jonathan R. Clark,et al.  Prognostic Significance of Vascular Endothelial Growth Factor in Squamous Cell Carcinomas of the Tonsil in Relation to Human Papillomavirus Status and Epidermal Growth Factor Receptor , 2009, Annals of Surgical Oncology.

[22]  Albert C. Koong,et al.  The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas. , 2009, International journal of radiation oncology, biology, physics.

[23]  Y. Yen,et al.  Human papillomavirus infection as a prognostic factor in oropharyngeal squamous cell carcinomas treated in a prospective phase II clinical trial. , 2009, Anticancer research.

[24]  C. Jung,et al.  Relationship between vascular endothelial growth factor and Notch1 expression and lymphatic metastasis in tongue cancer , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[25]  J. Gutkind,et al.  Dysregulated molecular networks in head and neck carcinogenesis. , 2009, Oral Oncology.

[26]  Lun Zhang,et al.  Correlation of Notch1 expression and activation to cisplatin-sensitivity of head and neck squamous cell carcinoma. , 2009, Ai zheng = Aizheng = Chinese journal of cancer.

[27]  C. Tsien,et al.  EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  J. Siegfried,et al.  Immunohistochemical Analysis of Phosphotyrosine Signal Transducer and Activator of Transcription 3 and Epidermal Growth Factor Receptor Autocrine Signaling Pathways in Head and Neck Cancers and Metastatic Lymph Nodes , 2008, Clinical Cancer Research.

[29]  A. Chaturvedi,et al.  Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  E. Sturgis,et al.  Trends in head and neck cancer incidence in relation to smoking prevalence , 2007, Cancer.

[31]  A. Maity,et al.  Cellular responses to EGFR inhibitors and their relevance to cancer therapy. , 2007, Cancer letters.

[32]  H. Dienes,et al.  Combined analysis of HPV‐DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer , 2007, International journal of cancer.

[33]  E. Choi,et al.  HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c‐myc during tumor formation , 2007, International journal of cancer.

[34]  E. Munck‐Wikland,et al.  Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer , 2006, International journal of cancer.

[35]  M. Pierotti,et al.  Molecular and Cytogenetic Subgroups of Oropharyngeal Squamous Cell Carcinoma , 2006, Clinical Cancer Research.

[36]  T. Giordano,et al.  Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling. , 2005, Cancer cell.

[37]  J. Ioannidis,et al.  Prognostic Significance of Vascular Endothelial Growth Factor Immunohistochemical Expression in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis , 2005, Clinical Cancer Research.

[38]  L. Ellis,et al.  Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  K. Raj,et al.  The role of Notch in tumorigenesis: oncogene or tumour suppressor? , 2003, Nature Reviews Cancer.

[40]  M Gion,et al.  Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. , 2002, European journal of cancer.

[41]  L. Bresler*,et al.  Increased expression of the vascular endothelial growth factor is a pejorative prognosis marker in papillary thyroid carcinoma. , 2001, The Journal of clinical endocrinology and metabolism.

[42]  J. Folkman.  What is the evidence that tumors are angiogenesis dependent? , 1990, Journal of the National Cancer Institute.

[43]  Yu-Jie Liang,et al.  Activation of Notch signaling in human tongue carcinoma. , 2011, Journal of Oral Pathology & Medicine.

[44]  Shi-fang Zhao,et al.  Downregulation of Notch1 and its potential correlation with epidermal growth factor receptor signalling in tongue squamous cell carcinoma. , 2010, The British journal of oral & maxillofacial surgery.

[45]  S. Eccles,et al.  C-erbB receptors in squamous cell carcinomas of the head and neck: clinical significance and correlation with matrix metalloproteinases and vascular endothelial growth factors. , 2002, Oral oncology.